关键词: 　卵巢癌, 高凝状态, 白细胞介素-6

Abstract:      The incidence of venous thromboembolism in patients with ovarian cancer is much higher than other gynecologic cancers. Approximate 20% of ovarian cancer patients have hypercoagulable status during different phases of their disease. Ovarian cancer itself can induce hypercoagulability, but meanwhile the over activated coagulation system may promote disease progression. Coagulation system disorder is one of the most important prognostic factors in ovarian cancer. Recently, hypercoagulability becomes a hot spot in the ovarian cancer research field. This article reviews the mechanism of hypercoagulability, its clinical implication and correlated treatment in ovarian cancer patients.

Key words: Ovarian cancer, Hypercoagulability, Interleukin-6